Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Gilead Sciences, Second Genome form IBD drug discovery alliance Gilead Sciences has entered into a four-year deal worth up to $338 million with California-based clinical-stage company Second… bypharmanewsdailyApril 9, 2020